Literature DB >> 20172029

Codon optimization enhances secretory expression of Pseudomonas aeruginosa exotoxin A in E. coli.

Xingxing Wang1, Xiujin Li, Zhenlong Zhang, Xinliang Shen, Fei Zhong.   

Abstract

Pseudomonas aeruginosa exotoxin A (PEA) is a number of family of bacterial ADP-ribosylating toxins and possesses strong immunogenicity. The detoxified exotoxin A, as a potent vaccine adjuvant and vaccine carrier protein, has been extensively used in human and animal vaccinations. However, the expression level of PEA gene in Escherichia coli is relative low which is likely due to the presence of rare codon and high levels of GC content. In order to enhance PEA gene expression, we optimized PEA gene using E. coli preferred codons and expressed it in E. coli BL21 (DE3) by using pET-20b(+) secretory expression vector. Our results showed that codon optimization significantly reduced GC content and enhanced PEA gene expression (70% increase compared with that of the wild-type). Moreover, the codon-optimized PEA possessed biological activity and had the similar toxic effects on mouse L292 cells compared with the wild-type PEA gene. Codon optimization will not only improve PEA gene expression but also benefit further modification of PEA gene using nucleotide-mediated site-directed mutagenesis. A large number of purified PEA proteins will provide the necessary conditions for further PEA functional research and application. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20172029     DOI: 10.1016/j.pep.2010.02.011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   2.025


  9 in total

1.  Comparison of two codon optimization strategies to enhance recombinant protein production in Escherichia coli.

Authors:  Hugo G Menzella
Journal:  Microb Cell Fact       Date:  2011-03-03       Impact factor: 5.328

2.  Codon-Optimized NADH Oxidase Gene Expression and Gene Fusion with Glycerol Dehydrogenase for Bienzyme System with Cofactor Regeneration.

Authors:  Baishan Fang; Wei Jiang; Qiang Zhou; Shizhen Wang
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

3.  Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi; Hamid Rajabi Memari; Ali Reza Samarbafzadeh
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

4.  Codon optimization with deep learning to enhance protein expression.

Authors:  Hongguang Fu; Yanbing Liang; Xiuqin Zhong; ZhiLing Pan; Lei Huang; HaiLin Zhang; Yang Xu; Wei Zhou; Zhong Liu
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

5.  mRNA codon optimization with quantum computers.

Authors:  Dillion M Fox; Kim M Branson; Ross C Walker
Journal:  PLoS One       Date:  2021-10-29       Impact factor: 3.240

6.  Codon preference optimization increases prokaryotic cystatin C expression.

Authors:  Qing Wang; Cui Mei; Honghua Zhen; Jess Zhu
Journal:  J Biomed Biotechnol       Date:  2012-10-03

Review 7.  Expression of codon optimized genes in microbial systems: current industrial applications and perspectives.

Authors:  Claudia Elena; Pablo Ravasi; María E Castelli; Salvador Peirú; Hugo G Menzella
Journal:  Front Microbiol       Date:  2014-02-04       Impact factor: 5.640

8.  Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus.

Authors:  Reza Taherkhani; Manoochehr Makvandi; Fatemeh Farshadpour
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

9.  Construction of Bacillus subtilis strain engineered for expression of porcine β-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity.

Authors:  Jian Xu; Fei Zhong; Yonghong Zhang; Jianlou Zhang; Shanshan Huo; Hongyu Lin; Liyue Wang; Dan Cui; Xiujin Li
Journal:  Asian-Australas J Anim Sci       Date:  2016-06-30       Impact factor: 2.509

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.